| Year |
Citation |
Score |
| 2016 |
Campbell TM, Castro MA, de Santiago I, Fletcher MN, Halim S, Prathalingam R, Ponder BA, Meyer KB. FGFR2 risk SNPs confer breast cancer risk by augmenting estrogen responsiveness. Carcinogenesis. PMID 27236187 DOI: 10.1093/carcin/bgw065 |
0.34 |
|
| 2015 |
Castro MA, de Santiago I, Campbell TM, Vaughn C, Hickey TE, Ross E, Tilley WD, Markowetz F, Ponder BA, Meyer KB. Regulators of genetic risk of breast cancer identified by integrative network analysis. Nature Genetics. PMID 26618344 DOI: 10.1038/ng.3458 |
0.364 |
|
| 2013 |
Jones JO, Chin SF, Wong-Taylor LA, Leaford D, Ponder BA, Caldas C, Maia AT. TOX3 mutations in breast cancer. Plos One. 8: e74102. PMID 24069272 DOI: 10.1371/journal.pone.0074102 |
0.362 |
|
| 2013 |
Fletcher MN, Castro MA, Wang X, de Santiago I, O'Reilly M, Chin SF, Rueda OM, Caldas C, Ponder BA, Markowetz F, Meyer KB. Master regulators of FGFR2 signalling and breast cancer risk. Nature Communications. 4: 2464. PMID 24043118 DOI: 10.1038/Ncomms3464 |
0.335 |
|
| 2012 |
Maia AT, Antoniou AC, O'Reilly M, Samarajiwa S, Dunning M, Kartsonaki C, Chin SF, Curtis CN, McGuffog L, Domchek SM, Easton DF, Peock S, Frost D, Evans DG, ... ... Ponder BA, et al. Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers. Breast Cancer Research : Bcr. 14: R63. PMID 22513257 DOI: 10.1186/bcr3169 |
0.332 |
|
| 2012 |
Cho HS, Toyokawa G, Daigo Y, Hayami S, Masuda K, Ikawa N, Yamane Y, Maejima K, Tsunoda T, Field HI, Kelly JD, Neal DE, Ponder BA, Maehara Y, Nakamura Y, et al. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene. International Journal of Cancer. Journal International Du Cancer. 131: E179-89. PMID 22020899 DOI: 10.1002/ijc.26501 |
0.308 |
|
| 2011 |
Meyer KB, Maia AT, O'Reilly M, Ghoussaini M, Prathalingam R, Porter-Gill P, Ambs S, Prokunina-Olsson L, Carroll J, Ponder BAJ. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression Plos Genetics. 7. PMID 21814516 DOI: 10.1371/Journal.Pgen.1002165 |
0.329 |
|
| 2011 |
Yoshimatsu M, Toyokawa G, Hayami S, Unoki M, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, Ponder BA, Nakamura Y, Hamamoto R. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. International Journal of Cancer. Journal International Du Cancer. 128: 562-73. PMID 20473859 DOI: 10.1002/ijc.25366 |
0.3 |
|
| 2010 |
Pooley KA, Tyrer J, Shah M, Driver KE, Leyland J, Brown J, Audley T, McGuffog L, Ponder BAJ, Pharoah PDP, Easton DF, Dunning AM. No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk Cancer Epidemiology Biomarkers and Prevention. 19: 1862-1865. PMID 20570912 DOI: 10.1158/1055-9965.EPI-10-0281 |
0.33 |
|
| 2010 |
Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock S, Cook M, Oliver C, Frost D, Sinilnikova OM, et al. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 19: 2886-97. PMID 20418484 DOI: 10.1093/Hmg/Ddq174 |
0.403 |
|
| 2010 |
Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, Bingham SA, Ponder BAJ, Pharoah PDP, Khaw KT, Easton DF, Dunning AM. Telomere length in prospective and retrospective cancer case-control studies Cancer Research. 70: 3170-3176. PMID 20395204 DOI: 10.1158/0008-5472.CAN-09-4595 |
0.331 |
|
| 2010 |
Azzato EM, Lee AJX, Teschendorff A, Ponder BAJ, Pharoah P, Caldas C, Maia AT. Common germ-line polymorphism of C1QA and breast cancer survival British Journal of Cancer. 102: 1294-1299. PMID 20332777 DOI: 10.1038/sj.bjc.6605625 |
0.386 |
|
| 2010 |
Udler MS, Ahmed S, Healey CS, Meyer K, Struewing J, Maranian M, Kwon EM, Zhang J, Tyrer J, Karlins E, Platte R, Kalmyrzaev B, Dicks E, Field H, Maia AT, ... ... Ponder BA, et al. Fine scale mapping of the breast cancer 16q12 locus. Human Molecular Genetics. 19: 2507-15. PMID 20332101 DOI: 10.1093/Hmg/Ddq122 |
0.343 |
|
| 2009 |
Maia AT, Spiteri I, Lee AJX, O'Reilly M, Jones L, Caldas C, Ponder BAJ. Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast Breast Cancer Research. 11. PMID 20003265 DOI: 10.1186/bcr2458 |
0.326 |
|
| 2009 |
Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, ... ... Ponder BA, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nature Genetics. 41: 996-1000. PMID 19648919 DOI: 10.1038/Ng.424 |
0.325 |
|
| 2009 |
Unoki M, Kelly JD, Neal DE, Ponder BAJ, Nakamura Y, Hamamoto R. UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer British Journal of Cancer. 101: 98-105. PMID 19491893 DOI: 10.1038/sj.bjc.6605123 |
0.32 |
|
| 2009 |
Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, ... ... Ponder BA, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Human Molecular Genetics. 18: 2297-304. PMID 19304784 DOI: 10.1093/Hmg/Ddp138 |
0.4 |
|
| 2009 |
Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, ... ... Ponder BA, et al. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer. 100: 993-1001. PMID 19240718 DOI: 10.1038/Sj.Bjc.6604947 |
0.312 |
|
| 2009 |
Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, RodrÃguez R, Barbosa-Morais NL, Ponder BA, Low YL, Bingham S, Haiman CA, Le Marchand L, et al. Association of ESR1 gene tagging SNPs with breast cancer risk. Human Molecular Genetics. 18: 1131-9. PMID 19126777 DOI: 10.1093/Hmg/Ddn429 |
0.377 |
|
| 2009 |
Mavaddat N, Dunning AM, Ponder BAJ, Easton DF, Pharoah PD. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer Cancer Epidemiology Biomarkers and Prevention. 18: 255-259. PMID 19124506 DOI: 10.1158/1055-9965.EPI-08-0704 |
0.35 |
|
| 2008 |
Kalmyrzaev B, Pharoah PDP, Easton DF, Ponder BAJ, Dunning AM. Hyaluronan-mediated motility receptor gene single nucleotide polymorphisms and risk of breast cancer Cancer Epidemiology Biomarkers and Prevention. 17: 3618-3620. PMID 19064580 DOI: 10.1158/1055-9965.EPI-08-0216 |
0.331 |
|
| 2008 |
Thompson DJ, Healey CS, Baynes C, Kalmyrzaev B, Ahmed S, Dowsett M, Folkerd E, Luben RN, Cox D, Ballinger D, Pharoah PD, Ponder BA, Dunning AM, Easton DF. Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3490-8. PMID 19064566 DOI: 10.1158/1055-9965.Epi-08-0734 |
0.357 |
|
| 2008 |
Pooley KA, Baynes C, Driver KE, Tyrer J, Azzato EM, Pharoah PD, Easton DF, Ponder BA, Dunning AM. Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3482-9. PMID 19064565 DOI: 10.1158/1055-9965.Epi-08-0594 |
0.377 |
|
| 2008 |
Song H, Koessler T, Ahmed S, Ramus SJ, Kjaer SK, Dicioccio RA, Wozniak E, Hogdall E, Whittemore AS, McGuire V, Ponder BA, Turnbull C, Hines S, Rahman N, et al. Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer. Cancer Research. 68: 8837-42. PMID 18974127 DOI: 10.1158/0008-5472.Can-08-2363 |
0.387 |
|
| 2008 |
Mann A, Hogdall E, Ramus SJ, DiCioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D, Easton DF, Ponder BA, Kjaer SK, Gayther SA, Thompson DJ, et al. Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. European Journal of Cancer (Oxford, England : 1990). 44: 2259-65. PMID 18723338 DOI: 10.1016/J.Ejca.2008.07.010 |
0.303 |
|
| 2008 |
Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, ... ... Ponder BA, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. Journal of the National Cancer Institute. 100: 962-6. PMID 18577746 DOI: 10.1093/Jnci/Djn190 |
0.382 |
|
| 2008 |
Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, Caldas C, Ponder BAJ. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer Plos Biology. 6: 1098-1103. PMID 18462018 DOI: 10.1371/journal.pbio.0060108 |
0.366 |
|
| 2008 |
Mulvany F, Ponder BAJ. Breast Cancer Research - the first ten years Breast Cancer Research. 10. PMID 18341713 DOI: 10.1186/bcr1873 |
0.305 |
|
| 2008 |
Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, Tyrer JP, Ponder BAJ, Easton DF, Pharoahm PDP, Dunning AM, Abraham J, Antoniou A, Baynes C, Benusiglio P, Blows F, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population Carcinogenesis. 29: 333-341. PMID 18174243 DOI: 10.1093/carcin/bgm284 |
0.35 |
|
| 2007 |
Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, Pharoah PD, Gayther SA. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Human Mutation. 28: 1207-15. PMID 17688236 DOI: 10.1002/Humu.20599 |
0.342 |
|
| 2007 |
Udler M, Maia AT, Cebrian A, Brown C, Greenberg D, Shah M, Caldas C, Dunning A, Easton D, Ponder B, Pharoah P. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer Journal of Clinical Oncology. 25: 3015-3023. PMID 17634480 DOI: 10.1200/JCO.2006.10.0099 |
0.387 |
|
| 2007 |
Baynes C, Healey CS, Pooley KA, Scollen S, Luben RN, Thompson DJ, Pharoah PD, Easton DF, Ponder BA, Dunning AM. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. Breast Cancer Research : Bcr. 9: R27. PMID 17428325 DOI: 10.1186/Bcr1669 |
0.415 |
|
| 2007 |
Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... ... Ponder BA, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261 |
0.311 |
|
| 2007 |
Samuelson DJ, Hesselson SE, Aperavich BA, Zan Y, Haag JD, Trentham-Dietz A, Hampton JM, Mau B, Chen KS, Baynes C, Khaw KT, Luben R, Perkins B, Shah M, Pharoah PD, ... ... Ponder BA, et al. Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk. Proceedings of the National Academy of Sciences of the United States of America. 104: 6299-304. PMID 17404222 DOI: 10.1073/Pnas.0701687104 |
0.379 |
|
| 2007 |
Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA, Whittemore AS, McGuire V, Hogdall C, Jacobs IJ, Easton DF, Ponder BA, Dunning AM, Gayther SA, Pharoah PD. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. Plos One. 2: e268. PMID 17342202 DOI: 10.1371/Journal.Pone.0000268 |
0.405 |
|
| 2007 |
Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nature Genetics. 39: 352-8. PMID 17293864 DOI: 10.1038/Ng1981 |
0.377 |
|
| 2007 |
Pharoah PDP, Tyrer J, Dunning AM, Easton DF, Ponder BAJ, Abraham J, Al-Zahrani A, Baynes C, Blows F, Cebrian A, Conroy D, Dew G, Driver K, Field H, Gregory K, et al. Association between common variation in 120 candidate genes and breast cancer risk Plos Genetics. 3: 0401-0406. DOI: 10.1371/journal.pgen.0030042 |
0.378 |
|
| 2007 |
Pharoah PDP, Ponder BAJ. The polygenic basis of breast cancer Genes and Common Diseases. 224-232. DOI: 10.1017/CBO9780511543555.016 |
0.336 |
|
| 2006 |
Sternlicht MD, Dunning AM, Moore DH, Pharoah PD, Ginzinger DG, Chin K, Gray JW, Waldman FM, Ponder BA, Werb Z. Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2107-14. PMID 17119035 DOI: 10.1158/1055-9965.Epi-06-0351 |
0.368 |
|
| 2006 |
Benusiglio PR, Pharoah PD, Smith PL, Lesueur F, Conroy D, Luben RN, Dew G, Jordan C, Dunning A, Easton DF, Ponder BA. HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer. British Journal of Cancer. 95: 1689-95. PMID 17117180 DOI: 10.1038/sj.bjc.6603473 |
0.377 |
|
| 2006 |
Song H, Ramus SJ, Shadforth D, Quaye L, Kjaer SK, Dicioccio RA, Dunning AM, Hogdall E, Hogdall C, Whittemore AS, McGuire V, Lesueur F, Easton DF, Jacobs IJ, Ponder BA, et al. Common variants in RB1 gene and risk of invasive ovarian cancer. Cancer Research. 66: 10220-6. PMID 17047088 DOI: 10.1158/0008-5472.Can-06-2222 |
0.334 |
|
| 2006 |
Oestergaard MZ, Tyrer J, Cebrian A, Shah M, Dunning AM, Ponder BAJ, Easton DF, Pharoah PDP. Interactions between genes involved in the antioxidant defence system and breast cancer risk British Journal of Cancer. 95: 525-531. PMID 16868544 DOI: 10.1038/sj.bjc.6603272 |
0.353 |
|
| 2006 |
El-Tanani MK, Campbell FC, Crowe P, Erwin P, Harkin DP, Pharoah P, Ponder B, Rudland PS. BRCA1 suppresses osteopontin-mediated breast cancer. The Journal of Biological Chemistry. 281: 26587-601. PMID 16807234 DOI: 10.1074/Jbc.M604403200 |
0.364 |
|
| 2006 |
Song H, Ramus SJ, Quaye L, DiCioccio RA, Tyrer J, Lomas E, Shadforth D, Hogdall E, Hogdall C, McGuire V, Whittemore AS, Easton DF, Ponder BA, Kjaer SK, Pharoah PD, et al. Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis. 27: 2235-42. PMID 16774946 DOI: 10.1093/Carcin/Bgl089 |
0.358 |
|
| 2006 |
Lesueur F, Song H, Ahmed S, Luccarini C, Jordan C, Luben R, Easton DF, Dunning AM, Pharoah PD, Ponder BA. Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population. British Journal of Cancer. 94: 1921-6. PMID 16685266 DOI: 10.1038/Sj.Bjc.6603160 |
0.382 |
|
| 2006 |
Pooley KA, Healey CS, Smith PL, Pharoah PD, Thompson D, Tee L, West J, Jordan C, Easton DF, Ponder BA, Dunning AM. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 675-82. PMID 16614108 DOI: 10.1158/1055-9965.EPI-05-0679 |
0.337 |
|
| 2006 |
Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, Smith PL, Conroy D, Luben R, Perkins B, Easton DF, Dunning AM, Esteller M, Ponder BA. Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis. 27: 1661-9. PMID 16501248 DOI: 10.1093/Carcin/Bgi375 |
0.325 |
|
| 2006 |
Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BA. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Research. 66: 1225-33. PMID 16424062 DOI: 10.1158/0008-5472.Can-05-1857 |
0.412 |
|
| 2006 |
Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Human Molecular Genetics. 15: 1-10. PMID 16306136 DOI: 10.1093/Hmg/Ddi398 |
0.385 |
|
| 2005 |
Ponder BAJ, Antoniou A, Dunning A, Easton DF, Pharoah PDP. Polygenic inherited predisposition to breast cancer Cold Spring Harbor Symposia On Quantitative Biology. 70: 35-41. PMID 16869736 DOI: 10.1101/sqb.2005.70.029 |
0.368 |
|
| 2005 |
Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, Giles GG, McCredie M, Chang-Claude J, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1828-31. PMID 16030124 DOI: 10.1158/1055-9965.EPI-04-0807 |
0.416 |
|
| 2005 |
Benusiglio PR, Lesueur F, Luccarini C, McIntosh J, Luben RN, Smith P, Dunning A, Easton DF, Ponder BA, Pharoah PD. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs. Bmc Cancer. 5: 81. PMID 16029503 DOI: 10.1186/1471-2407-5-81 |
0.387 |
|
| 2005 |
Lesueur F, Pharoah PD, Laing S, Ahmed S, Jordan C, Smith PL, Luben R, Wareham NJ, Easton DF, Dunning AM, Ponder BA. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer. Human Molecular Genetics. 14: 2349-56. PMID 16000320 DOI: 10.1093/hmg/ddi237 |
0.429 |
|
| 2005 |
Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B, Kjaer SK, Hogdall E, Hogdall C, Stratton J, Whittemore AS, Easton DF, Ponder BA, Novik KL, Dunning AM, Gayther S, et al. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. International Journal of Cancer. Journal International Du Cancer. 117: 611-8. PMID 15924337 DOI: 10.1002/Ijc.21047 |
0.313 |
|
| 2005 |
Benusiglio PR, Lesueur F, Luccarini C, Conroy DM, Shah M, Easton DF, Day NE, Dunning AM, Pharoah PD, Ponder BA. Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study. Breast Cancer Research : Bcr. 7: R204-9. PMID 15743501 DOI: 10.1186/Bcr982 |
0.39 |
|
| 2004 |
MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, Pharoah PD, Ponder BA, Meuth M, Bhattacharyya NP, Cox A. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. Journal of the National Cancer Institute. 96: 1866-9. PMID 15601643 DOI: 10.1093/Jnci/Dji001 |
0.398 |
|
| 2004 |
Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, et al. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. British Journal of Cancer. 91: 1911-5. PMID 15545966 DOI: 10.1038/Sj.Bjc.6602239 |
0.318 |
|
| 2004 |
Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Hogdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, et al. STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1589-94. PMID 15466974 |
0.34 |
|
| 2003 |
Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, Chia S, Ragaz J, Cahn A, ... ... Ponder B, et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell. 115: 523-35. PMID 14651845 DOI: 10.1016/S0092-8674(03)00930-9 |
0.391 |
|
| 2003 |
Jordan VC, Ponder BAJ. Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy Breast Cancer Research. 5: 281-283. PMID 14580241 DOI: 10.1186/bcr646 |
0.309 |
|
| 2003 |
Kuschel B, Auranen A, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD. Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 809-12. PMID 12917215 |
0.41 |
|
| 2003 |
Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Research. 63: 2610-5. PMID 12750287 |
0.366 |
|
| 2003 |
Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nature Genetics. 33: 238-44. PMID 12610533 DOI: 10.1038/Ng1107 |
0.336 |
|
| 2003 |
Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, Ayhan A, Wells D, Fishman A, Gore M, DiCioccio RA, Piver MS, Whittemore AS, Ponder BA, Gayther SA. BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. Cancer Research. 63: 417-23. PMID 12543797 |
0.337 |
|
| 2003 |
Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardern-Jones A, Murkin A, Dowe A, Kelly J, ... ... Ponder BA, et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. American Journal of Human Genetics. 72: 1-12. PMID 12474142 DOI: 10.1086/345310 |
0.307 |
|
| 2003 |
Auranen A, Spurdle AB, Chen X, Lipscombe J, Purdie DM, Hopper JL, Green A, Healey CS, Redman K, Dunning AM, Pharoah PD, Easton DF, Ponder BA, Chenevix-Trench G, Novik KL. BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk. International Journal of Cancer. 103: 427-30. PMID 12471628 DOI: 10.1002/ijc.10814 |
0.39 |
|
| 2002 |
Pharoah PDP, Ponder BAJ. The genetics of ovarian cancer Best Practice and Research: Clinical Obstetrics and Gynaecology. 16: 449-468. PMID 12413928 DOI: 10.1053/beog.2002.0296 |
0.335 |
|
| 2002 |
Tereshchenko IV, Béshém VM, Slonimskaia EM, Ponder BA, Férokh PD, Velichko SA, Shagiakhmetova RA. Investigation of mutations of BRCA1 and BRCA2 genes in 52 breast cancer patients Voprosy Onkologii. 48: 24-28. PMID 12101561 |
0.39 |
|
| 2002 |
Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, Easton DF, Pharoah PP. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Research. 62: 3052-7. PMID 12036913 |
0.316 |
|
| 2002 |
Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BAJ, Easton DF, Pharoah PDP. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer Breast Cancer Research. 4. PMID 11879560 DOI: 10.1186/bcr419 |
0.381 |
|
| 2002 |
Antoniou AC, Pharoah PDP, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes British Journal of Cancer. 86: 76-83. PMID 11857015 DOI: 10.1038/sj.bjc.6600008 |
0.385 |
|
| 2002 |
Tereschenko IV, Basham VM, Ponder BAJ, Pharoah PDP. BRCA1 and BRCA2 mutations in Russian familial breast cancer Human Mutation. 19: 184. PMID 11793480 |
0.347 |
|
| 2002 |
Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, Hopper JL, Buys SS, Andrulis IL, ... ... Ponder BA, et al. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proceedings of the National Academy of Sciences of the United States of America. 99: 827-31. PMID 11792833 DOI: 10.1073/Pnas.012584499 |
0.351 |
|
| 2001 |
Basham VM, Pharoah PD, Healey CS, Luben RN, Day NE, Easton DF, Ponder BA, Dunning AM. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk. Carcinogenesis. 22: 1797-800. PMID 11698341 |
0.349 |
|
| 2001 |
Antoniou AC, Pharoah PDP, McMullan G, Day NE, Ponder BAJ, Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study Genetic Epidemiology. 21: 1-18. PMID 11443730 DOI: 10.1002/gepi.1014 |
0.371 |
|
| 2001 |
Ponder BAJ. Cancer genetics Nature. 411: 336-341. PMID 11357140 DOI: 10.1038/35077207 |
0.324 |
|
| 2000 |
Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder BA, Piver MS. Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 19: 390-4. PMID 11109172 DOI: 10.1097/00004347-200010000-00017 |
0.352 |
|
| 2000 |
Healey CS, Dunning AM, Teare MD, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nature Genetics. 26: 362-4. PMID 11062481 DOI: 10.1038/81691 |
0.4 |
|
| 2000 |
Ponder BAJ, Day NE, Easton DF, Pharoah PDP, Lipscombe JM, Redman K, Antoniou A, Basham V, Gregory J, Gayther S, Dunning A. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases British Journal of Cancer. 83: 1301-1308. PMID 11044354 |
0.372 |
|
| 2000 |
Gayther SA, De Foy KAF, Harrington P, Pharoah P, Dunsmuir WD, Edwards SM, Gillett C, Ardern-Jones A, Dearnaley DP, Easton DF, Ford D, Shearer RJ, Kirby RS, Dowe AL, Kelly J, ... ... Ponder BAJ, et al. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer Cancer Research. 60: 4513-4518. PMID 10969800 |
0.313 |
|
| 2000 |
Russell PA, Pharoah PD, De Foy K, Ramus SJ, Symmonds I, Wilson A, Scott I, Ponder BA, Gayther SA. Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. International Journal of Cancer. Journal International Du Cancer. 87: 317-21. PMID 10897034 DOI: 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B |
0.307 |
|
| 2000 |
Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. Journal of the National Cancer Institute. 92: 1088-91. PMID 10880552 DOI: 10.1093/Jnci/92.13.1088 |
0.32 |
|
| 2000 |
Sutcliffe S, Pharoah PDP, Easton DF, Ponder BAJ, Ponder B, Easton D, Fraser G, Jacobs I, Mackay J, Twentyman P, Bishop T, Lowe D, Lakhani S, Steel M. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer International Journal of Cancer. 87: 110-117. PMID 10861460 DOI: 10.1002/1097-0215(20000701)87:1<110::Aid-Ijc16>3.0.Co;2-6 |
0.376 |
|
| 2000 |
Pharoah PDP, Lipscombe JM, Redman KL, Day NE, Easton DF, Ponder BAJ. Familial predisposition to breast cancer in a British population: Implications for prevention European Journal of Cancer. 36: 773-779. PMID 10762751 DOI: 10.1016/S0959-8049(00)00023-X |
0.348 |
|
| 2000 |
Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, ... ... Ponder BA, et al. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 782-9. PMID 10741697 |
0.356 |
|
| 2000 |
Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JDA, Ponder BAJ, Kouzarides T, Caldas C. Mutations truncating the EP300 acetylase in human cancers Nature Genetics. 24: 300-303. PMID 10700188 DOI: 10.1038/73536 |
0.379 |
|
| 2000 |
Seltmann M, Harrington P, Ponder BAJ, Willatt LR, Heppell-Parton AC, Anton-Culver H. A case of inv dup(8p) with early onset breast cancer Journal of Medical Genetics. 37: 70-71. PMID 10691415 |
0.316 |
|
| 2000 |
Healey CS, Dunning AM, Durocher F, Teare D, Pharoah PD, Luben RN, Easton DF, Ponder BA. Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis. 21: 189-93. PMID 10657957 |
0.409 |
|
| 2000 |
Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF. Risk models for familial ovarian and breast cancer. Genetic Epidemiology. 18: 173-90. PMID 10642429 DOI: 10.1002/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R |
0.383 |
|
| 1999 |
Ponder BAJ. Breast cancer research: A meeting point as well as a journal Breast Cancer Research. 1: 1. |
0.305 |
|
| Show low-probability matches. |